Claim Ownership

Author:

Subscribed: 0Played: 0
Share

Description

 Episodes
Reverse
Dr. Edward Grow is an Assistant Professor at the University of Texas, Southwestern. His lab studies reproductive biology, specifically the development of the egg and subsequently the fertilized embryo. He talks about regulating totipotency in ESCs, retroviral reactivation, and ex vivo culturing of follicles and oocytes.
Dr. Prisca Liberali is Senior Group Leader at the Friedrich Miescher Institute for Biomedical Research and an Assistant Professor at the University of Basel. Her research aims to understand the collective properties of organoid systems and their patterns, including how these systems allow systematic perturbation by established methods for modulating gene expression. She studies self-organization, symmetry breaking, intestinal organoid development, gastruloids, and mechanosensing mechanisms.
Drs. Tenneille Ludwig, Peter Andrews, and Madeline Lancaster are members of the ISSCR Standards Initiative for Pluripotent Stem Cell Research. They discuss the need for basic and preclinical standards to ensure rigor and reproducibility in stem cell research. They also talk about standards for pluripotency and model systems, and the initiative's international focus.
Dr. Jackie Damen is a currently a Principal Scientist in Scientific Support for Hematology at STEMCELL Technologies, and was previously the Director of Contract Assay Services. She talks about the company's culture and growth, and how in her role, she teaches scientists and helps them conduct their experiments. She also discusses systems for drug screening and discovery, opportunities in industry, and her affinity for microscopy and photography.
Dr. Marian Hettiaratchi is an Assistant Professor at the Knight Campus at the University of Oregon. Her research focuses on affinity-based biomaterials to promote tissue and bone repair. She talks about the delivery vehicles for these biomaterials, and her recent work on heparin-mediated delivery of BMP-2 to promote bone regeneration.
Dr. Lydia Finley is an Assistant Member of the Cell Biology Program at Memorial Sloan Kettering Cancer Center. The Finley lab investigates how cellular metabolic pathways regulate cell fate decisions in stem cells and cancer cells. She talks about the metabolic profiles and needs of different cell types, her lab's discovery of an alternate TCA cycle, and how track and field led her to pursue metabolism research.
In June 2022, we attended the International Society for Stem Cell Research (ISSCR) annual meeting in San Francisco. We spoke with delegates to get their impressions of the meeting. They discussed the most memorable research presented and shared their thoughts on the challenges facing the stem cell field.
ISSCR 2022: Day 4

ISSCR 2022: Day 4

2022-06-1938:39

In June 2022, we attended the International Society for Stem Cell Research (ISSCR) annual meeting in San Francisco, and recorded daily episodes discussing highlights of the previous 24 hours. Here is the final of four special episodes from the meeting.
ISSCR 2022: Day 3

ISSCR 2022: Day 3

2022-06-1828:24

In June 2022, we attended the International Society for Stem Cell Research (ISSCR) annual meeting in San Francisco, and recorded daily episodes discussing highlights of the previous 24 hours. Here is the third of four special episodes from the meeting.
ISSCR 2022: Day 2

ISSCR 2022: Day 2

2022-06-1726:30

In June 2022, we attended the International Society for Stem Cell Research (ISSCR) annual meeting in San Francisco, and recorded daily episodes discussing highlights of the previous 24 hours. Here is the second of four special episodes from the meeting.
ISSCR 2022: Day 1

ISSCR 2022: Day 1

2022-06-1638:231

In June 2022, we attended the International Society for Stem Cell Research (ISSCR) annual meeting in San Francisco, and recorded daily episodes discussing highlights of the previous 24 hours. Here is the first of four special episodes from the meeting.
Dr. Michael Levin is the Director of the Allen Discovery Center and a Distinguished Professor of Biology at Tufts University. He is a cognitive biologist who utilizes model systems such as Xenopus to answer fundamental questions in developmental biology. He talks about regenerating frog legs, using bioelectricity to direct development, and the potential applications of xenobots.
Dr. Steven Stice is the DW Brooks Distinguished Professor and Director of the Regenerative Bioscience Center at the University of Georgia, and the Co-Founder and Chief Scientific Officer of ArunA Biomedical. He talks about his early work cloning rabbits and reprogramming blastomeres. He also discusses using exosomes to treat neurological diseases, helping trainees move into industry, and preserving endangered species.
Dr. Amritha Jaishankar is the Executive Director of the Maryland Stem Cell Research Fund (MSCRF). She is a scientist by training who has devoted her career to developing cures for debilitating and life-threatening conditions of our time and to advancing this field, through various roles in federal, university, and industry settings. She talks about the history of the MSCRF, its programs to promote the commercialization of stem cell-based technologies, and its role in the Maryland stem cell research ecosystem.
Dr. Ophir Klein is the inaugural Executive Director of Cedars-Sinai Guerin Children's and the David and Meredith Kaplan Distinguished Chair in Children's Health. He discusses his work on intestinal epithelium regeneration, which he will present at the “Tissue Fibrosis and Repair: Mechanism, Human Disease, and Therapies” Keystone Symposium taking place from June 12-16th in Keystone, Colorado. He also talks about mechanisms of tooth development, analyzing three-dimensional facial images to diagnose genetic syndromes, and how parasitic infections affect the intestinal stem cell niche.
Dr. David Hay is the Chair of Tissue Engineering at the University of Edinburgh, where his group is defining novel ways to produce liver tissue from PSCs. They use in vitro derived tissue to better model human liver physiology and to develop supportive cell based therapies for disease. Dr. Hay also founded Stimuliver, a company that is developing a disruptive liver implant to treat critically failing liver function in humans. He talks about hepatocyte differentiation, liver disease modeling, and automating the production of cell therapies.
Dr. Agnete Kirkeby is an Associate Professor at the University of Copenhagen and a Group Leader at Lund University. The Kirkeby group studies the factors involved in human neural subtype specification in order to enable production of specific neurons for understanding and treating neurological diseases. They apply advanced human stem cells models to understand how hundreds of human neuronal subtypes are formed during embryo development. She talks about moving stem cell therapies for Parkinson's disease from animal models to clinical trials, modeling neural tube development, and developing treatments for narcolepsy.
Dr. Melissa Little is the President, Keith Alm is the CEO, and Dr. Amander Clark is the Vice President of the International Society for Stem Cell Research (ISSCR). They discuss what they're looking forward to at the upcoming ISSCR 2022 meeting, and the future of the organization and the stem cell research community.
Dr. Kelly McNagny is a Professor of Medical Genetics and Biomedical Engineering at the University of British Columbia. His research program is focused on hematopoietic stem cell biology, specifically in understanding the signaling networks that regulate stem cell differentiation and how these cells interact with their microenvironment. He talks about how hematopoietic stem cell differentiation is related to chronic inflammatory disorders, targeting glycosylation in solid tumors, and his international career path.
Dr. Mingxia Gu is an Assistant Professor of Pediatrics at Cincinnati Children's Hospital. Her lab's goal is to develop novel therapies for the regeneration of the heart, lung, and vasculature in patients with congenital cardiac and pulmonary defects. She talks about developing lung organoids to study COVID-19, how multi-lineage organoids can mimic human tissues, and her lab's motto to "move fast and break things."
Comments (3)

Bita Sedaghati

Proud of you Leili👍🏻

Sep 8th
Reply

Sergio Viafara

greeting from Colombia

Jan 25th
Reply (1)
Download from Google Play
Download from App Store